← Open Payments lookup

JULIUS FOMENGIA: Open Payments

NPI 1538688684 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$756 in 34 payments from 15 companies in 2025. Trend: 2023 $570 · 2024 $393 · 2025 $756

Food & beverage: $756
CompanyPaymentsAmount
ABBVIE INC.6$164
Lilly USA, LLC5$127
PFIZER INC.3$87
Alkermes, Inc.3$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$49
Neurocrine BioSciences, Inc.2$42
Kowa Pharmaceuticals America, Inc.3$42
Otsuka America Pharmaceutical, Inc.2$41
Exact Sciences Corporation2$39
Lundbeck LLC1$26

Products named: VRAYLAR, MOUNJARO, ELIQUIS, REXULTI, ARISTADA, CAPLYTA, INGREZZA, ZORYVE.

Industry payments across MD — which companies pay providers there.